Selective Inhibitors for Cyclin-Dependent Kinases
This invention provides a class of compounds which are useful for specifically inhibiting cyclin-dependent kinases. This class of compounds finds use in treating diseases resulting from inappropriate activity of cyclin-dependent kinases, including cancer, viral infections (e.g., HIV) neurodegenerati...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | COOMBES RCDS LIOTTA DENNIS C SCHEIPER BODO SNYDER JAMES P SIWICKA ALEKSANDRA ALI SIMAK BARRETT ANTHONY G.M BRACKOW JAN JOGALEKAR ASHUTOSH S |
description | This invention provides a class of compounds which are useful for specifically inhibiting cyclin-dependent kinases. This class of compounds finds use in treating diseases resulting from inappropriate activity of cyclin-dependent kinases, including cancer, viral infections (e.g., HIV) neurodegenerative disorders (e.g. Alzheimer's disease), and cardiovascular disorders (e.g. atherosclerosis). Moreover, certain members of this class are particularly useful for inhibiting cyclin-dependent kinase 7 and are especially useful for the treatment of breast cancer. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2010261683A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2010261683A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2010261683A13</originalsourceid><addsrcrecordid>eNrjZDAMTs1JTS7JLEtV8MzLyEzKLMkvKlZIyy9ScK5MzsnM03VJLUjNS0nNK1HwzsxLLE4t5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGBkZmhmYWxo6GxsSpAgA6PiyA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Selective Inhibitors for Cyclin-Dependent Kinases</title><source>esp@cenet</source><creator>COOMBES RCDS ; LIOTTA DENNIS C ; SCHEIPER BODO ; SNYDER JAMES P ; SIWICKA ALEKSANDRA ; ALI SIMAK ; BARRETT ANTHONY G.M ; BRACKOW JAN ; JOGALEKAR ASHUTOSH S</creator><creatorcontrib>COOMBES RCDS ; LIOTTA DENNIS C ; SCHEIPER BODO ; SNYDER JAMES P ; SIWICKA ALEKSANDRA ; ALI SIMAK ; BARRETT ANTHONY G.M ; BRACKOW JAN ; JOGALEKAR ASHUTOSH S</creatorcontrib><description>This invention provides a class of compounds which are useful for specifically inhibiting cyclin-dependent kinases. This class of compounds finds use in treating diseases resulting from inappropriate activity of cyclin-dependent kinases, including cancer, viral infections (e.g., HIV) neurodegenerative disorders (e.g. Alzheimer's disease), and cardiovascular disorders (e.g. atherosclerosis). Moreover, certain members of this class are particularly useful for inhibiting cyclin-dependent kinase 7 and are especially useful for the treatment of breast cancer.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101014&DB=EPODOC&CC=US&NR=2010261683A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101014&DB=EPODOC&CC=US&NR=2010261683A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>COOMBES RCDS</creatorcontrib><creatorcontrib>LIOTTA DENNIS C</creatorcontrib><creatorcontrib>SCHEIPER BODO</creatorcontrib><creatorcontrib>SNYDER JAMES P</creatorcontrib><creatorcontrib>SIWICKA ALEKSANDRA</creatorcontrib><creatorcontrib>ALI SIMAK</creatorcontrib><creatorcontrib>BARRETT ANTHONY G.M</creatorcontrib><creatorcontrib>BRACKOW JAN</creatorcontrib><creatorcontrib>JOGALEKAR ASHUTOSH S</creatorcontrib><title>Selective Inhibitors for Cyclin-Dependent Kinases</title><description>This invention provides a class of compounds which are useful for specifically inhibiting cyclin-dependent kinases. This class of compounds finds use in treating diseases resulting from inappropriate activity of cyclin-dependent kinases, including cancer, viral infections (e.g., HIV) neurodegenerative disorders (e.g. Alzheimer's disease), and cardiovascular disorders (e.g. atherosclerosis). Moreover, certain members of this class are particularly useful for inhibiting cyclin-dependent kinase 7 and are especially useful for the treatment of breast cancer.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAMTs1JTS7JLEtV8MzLyEzKLMkvKlZIyy9ScK5MzsnM03VJLUjNS0nNK1HwzsxLLE4t5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGBkZmhmYWxo6GxsSpAgA6PiyA</recordid><startdate>20101014</startdate><enddate>20101014</enddate><creator>COOMBES RCDS</creator><creator>LIOTTA DENNIS C</creator><creator>SCHEIPER BODO</creator><creator>SNYDER JAMES P</creator><creator>SIWICKA ALEKSANDRA</creator><creator>ALI SIMAK</creator><creator>BARRETT ANTHONY G.M</creator><creator>BRACKOW JAN</creator><creator>JOGALEKAR ASHUTOSH S</creator><scope>EVB</scope></search><sort><creationdate>20101014</creationdate><title>Selective Inhibitors for Cyclin-Dependent Kinases</title><author>COOMBES RCDS ; LIOTTA DENNIS C ; SCHEIPER BODO ; SNYDER JAMES P ; SIWICKA ALEKSANDRA ; ALI SIMAK ; BARRETT ANTHONY G.M ; BRACKOW JAN ; JOGALEKAR ASHUTOSH S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2010261683A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>COOMBES RCDS</creatorcontrib><creatorcontrib>LIOTTA DENNIS C</creatorcontrib><creatorcontrib>SCHEIPER BODO</creatorcontrib><creatorcontrib>SNYDER JAMES P</creatorcontrib><creatorcontrib>SIWICKA ALEKSANDRA</creatorcontrib><creatorcontrib>ALI SIMAK</creatorcontrib><creatorcontrib>BARRETT ANTHONY G.M</creatorcontrib><creatorcontrib>BRACKOW JAN</creatorcontrib><creatorcontrib>JOGALEKAR ASHUTOSH S</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>COOMBES RCDS</au><au>LIOTTA DENNIS C</au><au>SCHEIPER BODO</au><au>SNYDER JAMES P</au><au>SIWICKA ALEKSANDRA</au><au>ALI SIMAK</au><au>BARRETT ANTHONY G.M</au><au>BRACKOW JAN</au><au>JOGALEKAR ASHUTOSH S</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Selective Inhibitors for Cyclin-Dependent Kinases</title><date>2010-10-14</date><risdate>2010</risdate><abstract>This invention provides a class of compounds which are useful for specifically inhibiting cyclin-dependent kinases. This class of compounds finds use in treating diseases resulting from inappropriate activity of cyclin-dependent kinases, including cancer, viral infections (e.g., HIV) neurodegenerative disorders (e.g. Alzheimer's disease), and cardiovascular disorders (e.g. atherosclerosis). Moreover, certain members of this class are particularly useful for inhibiting cyclin-dependent kinase 7 and are especially useful for the treatment of breast cancer.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2010261683A1 |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
title | Selective Inhibitors for Cyclin-Dependent Kinases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A51%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=COOMBES%20RCDS&rft.date=2010-10-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2010261683A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |